Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowHematopoietic Stem CellsBone Marrow CellsGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationBone Marrow PurgingHematologic NeoplasmsCombined Modality TherapyTransplantation ChimeraBone and BonesStem CellsBusulfanPeripheral Blood Stem Cell TransplantationLeukemiaCyclophosphamideTissue DonorsHematopoiesisGraft SurvivalTreatment OutcomeHistocompatibility TestingRecurrenceRemission InductionLiver TransplantationHistocompatibilityLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteAnemia, AplasticMelphalanBone Marrow DiseasesCarmustineColony-Forming Units AssayAntigens, CD34Time FactorsAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesHematopoietic Stem Cell MobilizationTransplantation, IsogeneicCord Blood Stem Cell TransplantationCell DifferentiationMice, Inbred C57BLHematologic DiseasesHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsSurvival AnalysisMultiple MyelomaMyelodysplastic SyndromesGraft vs Leukemia EffectLeukemia, MyeloidSurvival RateKidney TransplantationMyeloablative AgonistsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEtoposideHodgkin DiseaseDisease-Free SurvivalChimerismCytarabineMesenchymal Stem Cell TransplantationHLA AntigensFlow CytometryGranulocyte Colony-Stimulating FactorTransplantation ImmunologyAcute DiseaseFollow-Up StudiesBone Marrow ExaminationT-LymphocytesSalvage TherapySevere Combined ImmunodeficiencyCells, CulturedImmunosuppressionGraft RejectionLymphocyte TransfusionCell TransplantationGraft vs Tumor EffectLymphocyte DepletionRadiation ChimeraCell LineageBone RemodelingCell SeparationBone Marrow NeoplasmsLymphomaThiotepaPrognosisCytomegalovirus InfectionsHeart TransplantationSiblingsCyclosporineActuarial AnalysisVincristineVidarabineLeukocyte CountAntilymphocyte SerumBlood Cell Count